Cabinet of Ministers Decree № 829 as of 07.10.2015 «On Amendments Introduction into Licensing Authorities List» came into effect.
In accordance with the Decree № 829 the State Administration on Medicinal Products regained its authorities regarding licensing of manufacture, wholesale and retail trade and import of medicinal products (despite Active Pharmaceutical Ingredients).
As indicated on the official website of the State Administration on Medicinal Products the licensing is processed based on general procedures.
It is worth to mention that the prior version of Licensing Authorities List approved by the Cabinet of Ministers Decree № 609 as of 05.08.2015 designated State Administration on Medicinal Products and Drugs Control as licensing authority for manufacture, wholesale and retail trade and import of medicinal products (despite Active Pharmaceutical Ingredients). In its turn, State Administration on Medicinal Products and Drugs Control had to be established as a merger of State Administration on Medicinal Products and State Administration on Drugs Control in view of implementation of the state course on optimization of central executive authorities system. But as of today the Unified State Register of Enterprises and Organizations of Ukraine still does not contain any data on the state registration of State Administration on Medicinal Products and Drugs Control.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.
